Skip to main content
ABL Bio Inc. logo

ABL Bio Inc. — Investor Relations & Filings

Ticker · 298380 ISIN · KR7298380007 LEI · 9884007BRC71Y64NK235 KO Professional, scientific and technical activities
Open in API
Filings indexed 369 across all filing types
Latest filing 2021-11-12 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 298380

About ABL Bio Inc.

https://www.ablbio.com

ABL Bio Inc. is a clinical-stage biotechnology company specializing in the development of bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases. The company leverages several proprietary platforms. For central nervous system disorders, its 'Grabody-B' technology is a blood-brain barrier (BBB) penetrating shuttle designed to enhance drug delivery to the brain. In immuno-oncology, ABL Bio develops 4-1BB based bispecific antibodies aimed at minimizing toxicity and overcoming resistance to existing immunotherapies. The company is also advancing a pipeline of antibody-drug conjugates (ADCs) with an improved therapeutic index for conditions such as rare blood cancers. ABL Bio actively progresses its therapeutic candidates through clinical development.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Correction Report) for a previously filed stock option grant. It details changes to the number of shares and the status of the grantees. In the context of corporate filings, reports regarding stock option grants, amendments, or cancellations are classified under 'Regulatory Filings' (RNS) as they represent specific corporate disclosures that do not fit into the other specialized categories like Director's Dealing or Share Issue.
2021-11-12 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for ABL Bio Inc. (에이비엘바이오 주식회사) for the 3rd quarter of 2021. It contains detailed financial information, business descriptions, capital structure, and management discussions, which are characteristic of a comprehensive interim financial report. It is not an announcement of a report, but the report itself. 9M 2021
2021-11-12 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Correction Report) for a previously submitted stock option grant. It details changes to the number of shares granted due to employee resignations and updates the total status of stock options. This type of disclosure regarding changes in capital structure or employee compensation instruments (stock options) is classified as a regulatory filing related to share/capital changes.
2021-11-01 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and specifically lists new stock collateral loan contracts (주식담보대출 계약) for the company ABL Bio. This type of filing is a standard regulatory disclosure regarding major shareholding positions and changes in ownership/collateral, which falls under the 'Major Shareholding Notification' category.
2021-10-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the share ownership, changes in shareholding, and collateral agreements (stock-backed loans) of the company's major shareholders and special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-10-01 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and collateral agreements (stock-backed loans) of the company's major shareholders and special related parties. This falls under the 'Major Shareholding Notification' category as it tracks significant ownership levels and changes.
2021-09-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.